The Alpha Genesis Primate Research Center (AGPRC) is the designated Contract Research Organization (Primate CRO) of Alpha Genesis Incorporated (AGI). The AGPRC research team is dedicated to fighting diseases and seeks to substantially improve human and animal health worldwide. In partnership with government organizations, private foundations, and private industry, AGPRC scientists conduct studies seeking breakthrough discoveries leading to improved treatments and cures. The highly regulated study of nonhuman primates (NHPs) is critically important to medical progress worldwide, as investigations using nonhuman primate models often precedes clinical trials in humans and cannot be replicated any other way. With increased international competition (especially from mainland China) for nonhuman primate research and development resources, exacerbated dramatically by the coronavirus (COVID-19) pandemic, the AGPRC represents a unique and highly effective US-based resource for conducting such work.

The Alpha Genesis Primate Research Center is a full-service AAALAC-accredited facility that provides ready access to several thousand macaque primates maintained in our U.S. based facilities. Our domestic SPF primate breeding colonies are unique within the industry and  have been used in a wide variety of translational research applications across all stages of primate development, from pre-natal through juvenile, adolescent, adult, and geriatric. 

The Alpha Genesis Primate Research Center offers an extensive array of contract research capabilities from early discovery and proof-of-concept to developmental toxicology. Research areas include pharmacokinetics, compound screening, vaccine testing, efficacy assessment, pharmacology, and early lead optimization. The Center is a full-service facility that provides primate quarantine, colony maintenance, colony support, primate biological products,  and on site use.